Air Liquide (OTCMKTS:AIQUY) Short Interest Up 127.6% in March

Air Liquide (OTCMKTS:AIQUY) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 199,694 shares, an increase of 127.6% from the March 15th total of 87,750 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 524,877 shares, the short-interest ratio is currently 0.4 days.

Institutional Trading of Air Liquide

A hedge fund recently raised its stake in Air Liquide stock. GAMMA Investing LLC raised its holdings in Air Liquide (OTCMKTS:AIQUY) by 15.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,822 shares of the basic materials company’s stock after buying an additional 1,039 shares during the quarter. GAMMA Investing LLC’s holdings in Air Liquide were worth $324,000 at the end of the most recent quarter. 0.04% of the stock is owned by institutional investors and hedge funds.

Air Liquide Stock Performance

AIQUY opened at $44.28 on Tuesday. The stock’s 50 day moving average price is $40.38 and its two-hundred day moving average price is $39.10. The company has a quick ratio of 0.90, a current ratio of 1.14 and a debt-to-equity ratio of 0.37. Air Liquide has a 12-month low of $36.17 and a 12-month high of $44.30.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AIQUY. Kepler Capital Markets raised Air Liquide from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 31st. Zacks Research lowered Air Liquide from a “hold” rating to a “strong sell” rating in a report on Monday, March 30th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Air Liquide presently has an average rating of “Hold”.

About Air Liquide

Air Liquide is a Paris‑headquartered multinational that develops, manufactures and supplies industrial and medical gases, related equipment and services. Founded in 1902, the company has grown into a major global supplier of gases such as oxygen, nitrogen, argon, hydrogen and a wide range of specialty gases used across industrial, healthcare and research applications.

Its core activities include on‑site gas production, bulk and packaged gas distribution (cylinders and cryogenic deliveries), installation and maintenance of gas handling and storage equipment, and engineering for large industrial gas projects.